Alzheimer's disease secretase, app substrates therefor, and uses therefor
CA 2397786 A1 · Owner: Gurney, Mark · Inventors: Gurney, Mark; Bienkowski, Michael Jerome
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides the enzyme and enzymatic procedures for cleaving the .beta. secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and isolates and assays. An enzyme that cleaves the .alpha.-secretase site of APP also is provided. The invention further provides a modified APP protein and associated nucleic acids peptides, vectors, cells, and cell isolates and assays that are particularly , useful for identifying candidate therapeutics for treatment or prevention of Alzheimer's disease.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 22, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 22, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 22, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.